Strong Buy
Buy
Hold
Sell
Strong Sell
Consensus
| Date | Grading Company | New Grade | Previous Grade | Action | Price When Posted | News Title | Publisher |
|---|---|---|---|---|---|---|---|
| 2025-11-12 | Cowen & Co. | Hold | Hold | Hold | $70.7 | TD Cowen Reiterates Hold Rating on Avidity Biosciences (RN… | StreetInsider |
| 2025-10-29 | Cowen & Co. | Hold | Buy | Downgrade | $69.93 | TD Cowen Downgrades Avidity Biosciences (RNA) to Hold | StreetInsider |
| 2025-10-28 | RBC Capital | Sector Perform | N/A | Downgrade | $70 | RBC Capital Downgrades Avidity Biosciences (RNA) to Sector… | StreetInsider |
| 2025-10-27 | Citigroup | Neutral | Buy | Downgrade | $70 | Avidity Biosciences downgraded to Neutral from Buy at Citi | TheFly |
| 2025-10-27 | Roth Capital | Neutral | N/A | Downgrade | $49.15 | Avidity Biosciences downgraded to Neutral from Buy at Roth … | TheFly |
| 2025-10-27 | Citigroup | Buy | Buy | Hold | $49.15 | Avidity Biosciences price target lowered to $72 from $75 at… | TheFly |
| 2025-10-27 | Needham | Hold | Buy | Downgrade | $49.15 | Avidity Biosciences downgraded to Hold from Buy at Needham | TheFly |
| 2025-10-27 | Raymond James | Market Perform | Strong Buy | Downgrade | $49.15 | Avidity Biosciences downgraded to Market Perform from Stron… | TheFly |
| 2025-10-27 | Bernstein | Market Perform | Outperform | Downgrade | $49.15 | Avidity Biosciences downgraded to Market Perform from Outpe… | TheFly |
| 2025-10-27 | H.C. Wainwright | Neutral | Buy | Downgrade | $49.15 | Avidity Biosciences downgraded to Neutral from Buy at H.C. … | TheFly |